BMC Cancer 2008, 8:213 http://www.biomedcentral.com/1471-2407/8/213 25. Hase K, Ueno H, Kuranaga N, Utsunomiya K, Kanabe S, Mochizuki H: Intraperitoneal exfoliated cancer cells in patients with color- ectal cancer. Dis Colon Rectum 1998, 41:1134-1140. 26. Lennon AM, Mulcahy HE, Hyland JM, Lowry C, White A, Fennelly D, Murphy JJ, O'Donoghue DP, Sheahan K: Peritoneal involvement in stage II colon cancer. Am J Clin Pathol 2003, 119:108-113. 27. Wang JY, Hsieh JS, Chang MY, Huang TJ, Chen FM, Cheng TL, Alex- andersen K, Huang YS, Tzou WS, Lin SR: Molecular detection of APC, K- ras, and p53 mutations in the serum of colorectal cancer patients as circulating biomarkers. World J Surg 2004, 28:721-726. 28. Vogel P, Ruschoff J, Kummel S, Zirngibl H, Hofstadter F, Hohenberger W, Jauch KW: Prognostic value of microscopic peritoneal dis- semination: comparison between colon and gastric cancer. Dis Colon Rectum 2000, 43:92-100. 29. Kanellos I, Demetriades H, Zintzaras E, Mandrali A, Mantzoros I, Bet- sis D: Incidence and prognostic value of positive peritoneal cytology in colorectal cancer. Dis Colon Rectum 2003, 46:535-539. 30. Wibe A, Moller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Soreide O: A national strategic change in treat- ment policy for rectal cancer--implementation of total mes- orectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002, 45:857-866. 31. Wibe A, Eriksen MT, Syse A, Tretli S, Myrvold HE, Soreide O: Effect of hospital caseload on long-term outcome after standardi- zation of rectal cancer surgery at a national level. Br J Surg 2005, 92:217-224. 32. Kristensen AT, Bjørheim J, Minarik M, Giercksky KE, Ekstrøm PO: Detection of mutations in exon 8 of TP53 by temperature gradient 96-capillary array electrophoresis. Biotechniques 2002, 33:650-653. 33. Umpleby HC, Fermor B, Symes MO, Williamson RC: Viability of exfoliated colorectal carcinoma cells. Br J Surg 1984, 71:659-663. 34. Skipper D, Cooper AJ, Marston JE, Taylor I: Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg 1987, 74:1049-1052. 35. Barry EL, Baron JA, Grau MV, Wallace K, Haile RW: K-ras muta- tions in incident sporadic colorectal adenomas. Cancer 2006, 106:1036-1040. 36. Smakman N, Borel R I, Voest EE, Kranenburg O: Control of color- ectal metastasis formation by K-Ras. Biochim Biophys Acta 2005, 1756:103-114. 37. Al Mulla F, MacKenzie EM: Differences in in vitro invasive capac- ity induced by differences in Ki-Ras protein mutations. J Pathol 2001, 195:549-556. 38. Andreyev HJ, Norman AR, Cunningham D, Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N, Beranek M, Jandik P, Ben- amouzig R, Jullian E, Laurent-Puig P, Olschwang S, Muller O, Hoffmann I, Rabes HM, Zietz C, Troungos C, Valavanis C, Yuen ST, Ho JW, Croke CT, O'Donoghue DP, Giaretti W, Rapallo A, Russo A, Bazan V, Tanaka M, Omura K, Azuma T, Ohkusa T, Fujimori T, Ono Y, Pauly M, Faber C, Glaesener R, de Goeij AF, Arends JW, Andersen SN, Lovig T, Breivik J, Gaudernack G, Clausen OP, De Angelis PD, Meling GI, Rognum TO, Smith R, Goh HS, Font A, Rosell R, Sun XF, Zhang H, Benhattar J, Losi L, Lee JQ, Wang ST, Clarke PA, Bell S, Quirke P, Bubb VJ, Piris J, Cruickshank NR, Morton D, Fox JC, Al Mulla F, Lees N, Hall CN, Snary D, Wilkinson K, Dillon D, Costa J, Pricolo VE, Fin- kelstein SD, Thebo JS, Senagore AJ, Halter SA, Wadler S, Malik S, Krtolica K, Urosevic N: Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer 2001, 85:692-696. 39. Lee JC, Wang ST, Lai MD, Lin YJ, Yang HB: K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers. Anticancer Res 1996, 16:3839-3844. 40. Benhattar J, Losi L, Chaubert P, Givel JC, Costa J: Prognostic signif- icance of K-ras mutations in colorectal carcinoma. Gastroen- terology 1993, 104:1044-1048. 41. Lievre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF, Cote JF, Tomasic G, Penna C, Ducreux M, Rougier P, Penault-Llorca F, Lau- rent-Puig P: KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 2006, 66:3992-3995. Pre-publication history The pre-publication history for this paper can be accessed here: http://www.biomedcentral.com/1471-2407/8/213/pre pub Publish with Bio Med Central and every scientist can read your work free of charge "BioMed Central will be the most significant development for disseminating the results of biomedical research in our lifetime." Sir Paul Nurse, Cancer Research UK Your research papers will be: available free of charge to the entire biomedical community peer reviewed and published immediately upon acceptance cited in PubMed and archived on PubMed Central yours — you keep the copyright Submit your manuscript here: http://www.biomedcentral.com/info/publishing_adv.asp BioMedcentral Page 8 of 8 (page number not for citation purposes)